Completed
Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
NCT02318836
- Conditions
- Digestive System Diseases, Hepatic Insufficiency, Liver Diseases, +1 more
- Locations
-
- Orlando Clinical Research Center Orlando, Florida, United States